Production (Stage)
Conduit Pharmaceuticals Inc.
CDT
$2.30
-$0.03-1.29%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.13M | 554.00K | 152.00K | 433.00K | 1.84M |
Total Receivables | 488.00K | -- | 734.00K | 188.00K | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 3.33M | 2.16M | 511.00K | 929.00K | 1.20M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | 51.00K | 114.00K |
Total Current Assets | 5.95M | 2.72M | 1.40M | 1.60M | 3.16M |
|
|||||
Total Current Assets | 5.95M | 2.72M | 1.40M | 1.60M | 3.16M |
Net Property, Plant & Equipment | 275.00K | 303.00K | 340.00K | 369.00K | 346.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.10M | 1.18M | 1.26M | 1.34M | 1.42M |
Total Assets | 7.32M | 4.19M | 2.99M | 3.31M | 4.92M |
|
|||||
Total Accounts Payable | 714.00K | 1.43M | 1.90M | 1.06M | 117.00K |
Total Accrued Expenses | 1.03M | 1.96M | 1.38M | 665.00K | 743.00K |
Short-term Debt | 2.66M | 6.28M | 118.00K | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 126.00K | 1.07M | 2.44M | 1.13M | 1.12M |
Total Finance Division Other Current Liabilities | 15.00K | -- | 6.15M | -- | 5.74M |
Total Other Current Liabilities | 15.00K | -- | 6.15M | -- | 5.74M |
Total Current Liabilities | 4.55M | 10.74M | 11.98M | 2.86M | 7.72M |
|
|||||
Total Current Liabilities | 4.55M | 10.74M | 11.98M | 2.86M | 7.72M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 2.66M | 6.28M | 118.00K | -- | -- |
Capital Leases | 78.00K | 107.00K | 110.00K | 141.00K | 171.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 8.00K | 138.00K | 24.00K | 5.77M | 123.00K |
Total Liabilities | 4.63M | 10.99M | 12.11M | 8.77M | 8.02M |
|
|||||
Common Stock & APIC | 36.59M | 21.89M | 17.31M | 14.39M | 11.36M |
Retained Earnings | -34.25M | -29.10M | -26.70M | -20.23M | -14.85M |
Treasury Stock & Other | 346.00K | 414.00K | 271.00K | 387.00K | 388.00K |
Total Common Equity | 2.69M | -6.79M | -9.12M | -5.46M | -3.10M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 2.69M | -6.79M | -9.12M | -5.46M | -3.10M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 2.69M | -6.79M | -9.12M | -5.46M | -3.10M |
|